Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 8/20 | 1.00 |
| ▸ | SHBG | P04278 | 7/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 1.00 |
| ▸ | TSHR | P16473 | 5/20 | 1.00 |
| ▸ | NR3C1 | P04150 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | PGR | P06401 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | ESR1 | P03372 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | AR | P10275 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | HTR2B | P41595 | 1/20 | 0.72 |
| ▸ | BLM | P54132 | 5/20 | 0.67 |
| ▸ | SERPINA6 | P08185 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethisterone SCHEMBL606819 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL15581276 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL14433089 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL12417537 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL24475 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL16864523 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL16691330 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL780055 | 1.00 | LMNA (1.00) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL28541256 | 0.99 | LMNA (0.98) | LMNASHBGSMN1; SMN2TSHRNR3C1 | |
| Ethisterone SCHEMBL11152514 | 0.96 | LMNA (0.92) | LMNASHBGSMN1; SMN2TSHRNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-9107959-B2 | Method for site-specific polyvalent display on polymers | NEW YORK UNIVERSITY (US) | 2015-08-18 | — | — | US | disclosed |
| US-9107959-B2 | Method for site-specific polyvalent display on polymers | NEW YORK UNIVERSITY (US) | 2015-08-18 | — | — | US | disclosed |
| US-8637569-B2 | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds | API GENESIS, LLC (US) | 2014-01-28 | — | — | US | disclosed |
| US-8637569-B2 | Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds | API GENESIS, LLC (US) | 2014-01-28 | — | — | US | disclosed |
| US-8524663-B2 | Method for site-specific polyvalent display on polymers | NEW YORK UNIVERSITY (US) | 2013-09-03 | — | — | US | disclosed |
| US-8524663-B2 | Method for site-specific polyvalent display on polymers | NEW YORK UNIVERSITY (US) | 2013-09-03 | — | — | US | disclosed |
| US-20120122779-A1 | Method for site-specific polyvalent display on polymers | NEW YORK UNIVERSITY | 2012-05-17 | — | — | US | disclosed |
| US-20120122779-A1 | Method for site-specific polyvalent display on polymers | NEW YORK UNIVERSITY | 2012-05-17 | — | — | US | disclosed |
| US-20080269425-A1 | Novel Catalyst | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080269425-A1 | Novel Catalyst | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| EP-1829610-A1 | NOVEL CATALYST | Wako Pure Chemical Industries, Ltd. (JP) | 2007-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269425-A1 | Novel Catalyst | PPOX, PNMT, POLRMT | LMNA 4732/4885SHBG 3647/4885SMN1; SMN2 4439/4885 |
| US-20120122779-A1 | Method for site-specific polyvalent display on polymers | NGLY1, DNPEP, GPKOW | LMNA 4246/4885SHBG 2928/4885SMN1; SMN2 4214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.